Top 4 Health Care Stocks That May Keep You Up At Night
Top 4 Health Care Stocks That May Keep You Up At Night
As of Sept. 24, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
截至2024年9月24日，醫療保健板塊中的四支股票可能對重視動能作爲交易決策關鍵標準的投資者發出真正的警告。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.
RSI是一種動量指標，它將股票在股價上升的日子裏的強度與在股價下跌的日子裏的強度進行比較。與股票價格的走勢相比，它可以讓交易員更好地了解股票在短期內的表現。當RSI高於70時，資產通常被認爲是超買的，據Benzinga Pro稱。
Here's the latest list of major overbought players in this sector.
以下是行業中超買的主要股票列表。
Doximity Inc (NYSE:DOCS)
Doximity公司（紐交所：DOCS）
- On Aug. 8, Doximity reported better-than-expected first-quarter financial results. Additionally, the company issued FY24 revenue guidance above estimates. "We were pleased to deliver strong profits and record engagement last quarter, as we beat on both our top and bottom lines," said Jeff Tangney, co-founder and CEO of Doximity. "Last quarter, a record 590,000 unique providers used our AI, telehealth, messaging, and scheduling workflow tools to save time and better serve their patients." The company's stock gained around 13% over the past month and has a 52-week high of $41.69.
- RSI Value: 82.05
- DOCS Price Action: Shares of Doximity gained 1.4% to close at $41.50 on Monday.
- 8月8日，Doximity報告了超出預期的第一季度財務結果。此外，該公司發佈了超過預期的FY24營業收入指引。「我們很高興在上個季度實現強勁利潤和創紀錄的參與度，因爲我們在我們的營業收入和底線上均取得了勝利，」 Doximity的聯合創始人兼首席執行官Jeff Tangney表示。「上個季度，創紀錄的59萬名獨特醫療服務提供者使用我們的人工智能、遠程醫療、消息傳遞和排班工具節省時間，更好地爲他們的患者提供服務。」該公司股價在過去一個月上漲了約13%，52周最高價爲41.69美元。
- RSI數值：82.05
- DOCS價格行動：Doximity的股票在週一上漲1.4%，收盤價爲41.50美元。
Gilead Sciences, Inc. (NASDAQ:GILD)
吉利德科學股份有限公司（納斯達克股票代碼：GILD）
- Gilead Sciences voluntarily recalled one lot of its COVID-19 treatment, Veklury (remdesivir), for Injection 100 mg/vial, after discovering glass particles in the vials. The company's stock gained around 9% over the past month and has a 52-week high of $87.86.
- RSI Value: 72.77
- GILD Price Action: Shares of Gilead Sciences rose 0.1% to close at $83.99 on Monday.
- 吉利德科學自願召回了一批COVID-19治療藥物瑞德西韋（remdesivir），規格爲100毫克/瓶注射液，在瓶中發現玻璃顆粒。該公司的股票在過去一個月內上漲了約9％，股價達到了87.86美元的52周高點。
- RSI值：72.77
- 吉利德科學股價走勢：週一，吉利德科學的股價上漲了0.1％，收盤價爲83.99美元。
Genfit SA (NASDAQ:GNFT)
Genfit SA（納斯達克：GNFT）
- On Sept. 19, Genfit posted H1 2024 adjusted EPS of €0.53 and revenues and other income of €61.199 million. The company's stock gained around 15% over the past five days and has a 52-week high of $6.05.
- RSI Value: 70.41
- GNFT Price Action: Shares of Genfit rose 3.1% to close at $4.99 on Monday.
- 9月19日，Genfit發佈了2024年上半年調整後的每股收益爲0.53歐元，營業收入及其他收入爲6119.9萬歐元。該公司的股票在過去五天內上漲了約15％，股價達到了6.05美元的52周高點。
- RSI值：70.41
- Genfit股價走勢：週一，Genfit的股價上漲了3.1％，收盤價爲4.99美元。
Bullfrog AI Holdings, Inc (NASDAQ:BFRG)
Bullfrog AI Holdings, Inc（納斯達克：BFRG）
- On July 25, BullFrog AI announced significant advancements in its ongoing collaboration with the Lieber Institute for Brain Development for specific molecular pathways associated with bipolar disorder, enabling the identification of new candidate drug targets. The company's stock has a 52-week high is $8.35.
- RSI Value: 78.66
- BFRG Price Action: Shares of Bullfrog AI gained 32.4% to close at $3.19 on Monday.
- 7月25日，BullFrog人工智能宣佈與利伯腦發展研究所合作取得重大進展，針對與躁鬱症相關的特定分子途徑，實現了新候選藥物靶標的識別。該公司股票的52周最高價爲8.35美元。
- RSI數值：78.66
- BFRG價格走勢：Bullfrog人工智能股價在週一上漲32.4%，收盤價爲3.19美元。
Read More:
閱讀更多：
- Jim Cramer Says This Utilities Stock Is A Buy: 'We Need Cheap Power'
- 吉姆·克雷默說，這家公用事業股票是一個買入：'我們需要廉價電力'
譯文內容由第三人軟體翻譯。